Robert S Radie
CIK 1591113 · Principal Financial Officer · last filed 2025-05-21
Robert S Radie is a Principal Financial Officer who has filed 43 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for RMTI, was dated May 21, 2025. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $89.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$89.7K
3
43
-$1.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RMTI | Director | 143,525 | $0.62 | $89.7K | $0 | 7 | 2025-05-21 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Director | 20,000 | $2.23 | $44.6K | -$69.4K | 12 | 2023-09-21 |
| Zyla Life Sciences (EGLT) Delisted | President and CEO | 834,900 | — | — | -$1.85M | 21 | 2018-06-15 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-21 | RMTI | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-05-23 | RMTI | Grant (A) | +36,111 | $0 | EDGAR |
| 2023-09-21 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Disp (D) | −73,000 | $0 | EDGAR |
| 2023-05-25 | RMTI | Grant (A) | +24,715 | $0 | EDGAR |
| 2023-02-09 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-06-09 | RMTI | Grant (A) | +25,000 | $0 | EDGAR |
| 2022-02-18 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2021-06-22 | RMTI | Grant (A) | +50,000 | $0 | EDGAR |
| 2021-02-22 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2020-05-20 | RMTI | Grant (A) | +31,000 | $0 | EDGAR |